363250.Kq
The company operates in the healthcare services and equipment industry, primarily engaged in the distribution of medical equipment and supplies.
Business. The company operates in the healthcare services and equipment industry, primarily engaged in the distribution of medical equipment and supplies.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
The company operates in the healthcare services and equipment industry, primarily engaged in the distribution of medical equipment and supplies.
The company's capital structure is characterized by a debt-to-equity ratio of 0.52, indicating a moderate level of leverage. Its liquidity position is marked by a current ratio of 1.08, suggesting a relatively balanced short-term liquidity profile. However, the company's cash and equivalents amount to 1,112,357,400 KRW, which is insufficient to cover its long-term debt of 4,045,388,720 KRW, resulting in a negative net cash position. The price-to-book ratio of 3.63 suggests that the market is valuing the company's equity at a premium relative to its book value.
Profitability metrics reveal a challenging financial situation. The company reported a net loss of 11,955,428,780 KRW, with a return on equity of -1.5225 and a return on assets of -0.8305, both significantly below the industry median for medical equipment and supplies distribution. The gross profit of -2,464,888,030 KRW and operating income of -15,965,120,140 KRW further underscore the company's operational inefficiencies.
The company's revenue is not segmented by geographic regions or product lines in the available data, making it difficult to assess the concentration of its revenue sources. However, the negative net cash position and high debt levels suggest a potential risk of over-reliance on a single market or product line.
The company's growth trajectory is currently negative, with a net loss and declining operating cash flow. The operating cash flow of -6,883,494,030 KRW and free cash flow of -13,985,073,660 KRW indicate a significant outflow of cash, which could hinder future growth initiatives. The capital expenditure of -334,284,810 KRW suggests that the company is not investing in new projects or infrastructure, which may further limit its growth potential.
The company faces several risk factors, including a negative net cash position and a high debt-to-equity ratio. The risk assessment indicates a medium liquidity risk and a low dilution risk. The negative net cash position after subtracting total debt is a key flag that could impact the company's ability to meet its short-term obligations. The dilution risk is low, but the company's financial performance and liquidity position could change if it needs to raise additional capital through equity issuance.
Recent events and filings do not provide specific details on the company's strategic initiatives or financial performance. The company's financial snapshot indicates a challenging operating environment, with significant losses and negative cash flows. The lack of detailed information on recent events or strategic moves makes it difficult to assess the company's future direction.
- The company is operating in a loss-making position with a net loss of 11,955,428,780 KRW.
- The company's liquidity position is moderate, with a current ratio of 1.08 and a negative net cash position.
- The company's profitability metrics are significantly below the industry median, indicating operational inefficiencies.
- The company is not investing in new projects or infrastructure, as indicated by the capital expenditure of -334,284,810 KRW.
- The company faces a medium liquidity risk and a low dilution risk, but its financial performance could change if it needs to raise additional capital.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Return On Equitynet_income / total_equity
- Price To Bookmarket_price / (adjusted_book_value / shares_outstanding_diluted)
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Market Priceinput from market-data provider (delayed close or quote-shim mid)
- Market Capmarket_price * shares_outstanding_diluted
- Ev To Revenueenterprise_value / revenue
- 363250.KQ Market data — financials · 2026-05-26